Dr. Ding is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Broad St
Bloomfield, NJ 07003Phone+1 973-873-7000Fax+1 973-743-8943
Summary
- Dr. William Ding is a radiation oncologist practicing at the NJU Cancer Center in Lawrenceville New Jersey. He is board certified in radiation oncology. He completed his undergraduate degree from the University of the Sciences in 1999. He worked at Merck & Co. as a clinical trials systems analyst from 2000-2003. He graduated from the Drexel University College of medicine in 2007 where he served as the class president. He completed his residency training in radiation oncology at the California Pacific Medical Center in San Francisco in 2012. He then served as an attending physician from 2012 to 2016 at the Crozer-Chester Medical Center in Chester, PA. He started his current position as the medical director of the NJU Cancer Center (formerly UCA) in 2016 where he specializes in genitourinary cancers. He is also an active board member on the external advisory board at the University of the Sciences in Philadelphia.
Education & Training
- California Pacific Medical CenterResidency, Radiation Oncology, 2008 - 2012
- Drexel University College of Medicine/Hahnemann University HospitalInternship, Internal Medicine, 2007 - 2008
- Drexel University College of MedicineClass of 2007
Certifications & Licensure
- NJ State Medical License 2015 - 2025
- PA State Medical License 2007 - 2024
- CA State Medical License 2008 - 2013
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013
Publications & Presentations
PubMed
- 11 citationsDefinitive Treatment of Early-Stage Non-Small Cell Lung Cancer with Stereotactic Ablative Body Radiotherapy in a Community Cancer Center SettingCory Heal, William Ding, John Lamond, Michael Wong, Rachelle Lanciano
Frontiers in Oncology. 2015-06-30 - 26 citationsSalvage fractionated stereotactic radiotherapy with or without chemotherapy and immunotherapy for recurrent glioblastoma multiforme: a single institution experienceShaakir Hasan, Eda Chen, Rachelle Lanciano, Jun Yang, A.L. Hanlon
Frontiers in Oncology. 2015-05-15 - 7 citationsTwelve-month prostate-specific antigen values and perineural invasion as strong independent prognostic variables of long-term biochemical outcome after prostate seed b...William Ding, John W. Lee, David Chamberlain, James Cunningham, Li-Xi Yang
International Journal of Radiation Oncology, Biology, Physics. 2012-11-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: